Dazed, Inc. (MEDH)
Cheyenne, WY, US
Dazed, Inc. engages in the management and expansion of its diverse array of counterculture brands, overseeing their retail presence, distribution networks, hospitality ventures, and licensing and franchising opportunities. The company, which commenced operations in 2004 and is headquartered in Cheyenne, Wyoming, officially rebranded from its former name, MedX Holdings, Inc., to Dazed, Inc. in October 2022.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +17.65% | +42.86% | +233.33% | +233.33% | +100.00% | +150.00% | +185.71% | +566.67% | +150.00% | +150.00% | +150.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Tobacco: +5.3%+97.1% ★ Q1'26: +56.3% (vs Q4'24)
-
EPS growth Tobacco: +18.8%+300.0% ★ Q1'26: +100.0% (vs Q4'24)
-
FCF margin FCF growth · Tobacco: +9.5%+4.2% Q1'26: +8.7% (vs Q4'24)
-
EBIT margin Tobacco: +20.5%+10.2% Q1'26: +17.4% (vs Q4'24)
-
ROIC Tobacco: +16.0%+1.4% Q1'26: +2.1% (vs Q4'24)
-
Share dilution Tobacco: +0.0%+0.0% Q1'26: +0.0% (vs Q4'24)
-
Debt / EBITDA Net debt/EBITDA · Tobacco: 0.25×25.94× Q1'26: 12.78× (vs Q4'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-27 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-26 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-22 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-20 | B+ | 3/5 | 1/5 | 3/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-19 | B+ | 3/5 | 1/5 | 3/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-18 | B+ | 3/5 | 1/5 | 3/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-15 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-05 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-01 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011-12-14 | Sullivan Mark | Officer | S-Sale | D | Common Stock | 2,447 | 9.17 | 22.4K | 36,821 | — | ↗ |
| 2011-12-13 | Sullivan Mark | Officer | S-Sale | D | Common Stock | 1,272 | 9.50 | 12.1K | 39,268 | — | ↗ |
| 2011-11-23 | O BRIEN COLIN | Director | — | D | Common Stock | 0 | 0.00 | — | 26,000 | — | ↗ |
| 2011-10-13 | Greczyn Robert J Jr | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2011-09-30 | Sullivan Mark | Officer | F-InKind | D | Common Stock | 1,226 | 9.62 | 11.8K | 34,595 | — | ↗ |
| 2011-07-11 | Sullivan Mark | Officer | F-InKind | D | Common Stock | 1,247 | 13.20 | 16.5K | 41,745 | — | ↗ |
| 2011-03-16 | Sullivan Mark | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2011-02-04 | SAC Capital Advisors LP | Director / 10% Owner | — | I | Common Stock, 0.10 par value | 0 | 0.00 | — | 15,768,938 | — | ↗ |
| 2011-02-04 | Berger Peter | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2011-02-04 | Baker Frank | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2011-02-04 | AQUILINA ROBERT M | Director / Officer | — | D | Employee Stock Option (Right to Buy) | 484,111 | 5.01 | 2.43M | 0 | — | ↗ |
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hans Enriquez | Chief Executive Officer, President & Director | — | male |
| Lori Frisher | Vice President of Marketing & Business Development | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MEDH
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
